• MDM1 Overexpression Enhances p53-Mediated Sensitivity in CRC

  2026-07-31

  A recent study reveals that MDM1 overexpression in colorectal cancer enhances p53 expression and apoptosis, increasing sensitivity to chemoradiotherapy. These findings identify MDM1 as a promising biomarker for predicting and improving treatment response, with implications for future translational research.

• JNK-IN-7: Advancing Translational Apoptosis and Immune Resea

  2026-07-31

  Explore how JNK-IN-7, a selective JNK inhibitor from APExBIO, empowers translational researchers to dissect apoptosis and innate immune signaling with unprecedented mechanistic clarity. By bridging recent findings on Candida krusei-induced apoptosis with advanced MAPK pathway research, this article offers actionable strategies, protocol guidance, and a forward-looking perspective for leveraging JNK-IN-7 in complex biological models.

• Haloprogin in Antifungal Research: Protocols, Performance, a

  2026-07-30

  Haloprogin, or 1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene, enables robust, reproducible studies of dermatophyte and Candida infections with a uniquely broad spectrum and dual antifungal-antibacterial profile. This guide translates the foundational reference study and modern product guidance into actionable experimental workflows, advanced applications, and practical troubleshooting tips.

• VX-765: Advanced Insights into Selective Caspase-1 Inhibitio

  2026-07-30

  Explore the scientific underpinnings of VX-765, a potent caspase-1 inhibitor, with a focus on new genomic screening insights, assay optimization, and translational applications. This article delivers a distinct, in-depth analysis of VX-765 and its metabolite VRT-043198 for researchers seeking advanced, practical guidance.

• Nonivamide (Capsaicin Analog): TRPV1 Modulation in Cancer an

  2026-07-29

  Nonivamide, a potent capsaicin analog, offers precise modulation of TRPV1 signaling with unique implications for cancer inhibition and sensory neuron studies. This article delivers a deep-dive into its mitochondrial apoptosis mechanisms, distinct assay optimization, and emerging neurocutaneous research directions.

• Tomivosertib: Advancing MNK1 Inhibition for Translational On

  2026-07-29

  Tomivosertib, a highly selective and orally available MNK1/2 inhibitor, disrupts oncogenic translation via the MNK-eIF4E axis—suppressing tumor growth, angiogenesis, and chemoresistance in preclinical glioblastoma models. This article explores mechanistic insights, translational benchmarks, and strategic guidance for researchers leveraging Tomivosertib as a precision tool in cancer and metabolic pathway interrogation, with direct reference to pivotal studies and current clinical trajectories.

• Tofacitinib Citrate in Immune Regulation: Applied Workflows

  2026-07-28

  Tofacitinib citrate (CP-690550 citrate) empowers targeted immune modulation in both classic JAK-STAT pathway and vascular inflammation models. This guide delivers experimental workflows, protocol parameters, and troubleshooting insights for reproducible, publication-ready results.

• TSPAN18 Stabilizes STIM1 to Drive Bone Metastasis in Prostat

  2026-07-28

  Zhou et al. identified TSPAN18 as a direct stabilizer of STIM1, protecting it from TRIM32-mediated ubiquitination and promoting calcium entry in prostate cancer cells. This discovery elucidates a novel mechanism underlying bone metastasis in hormone-responsive cancers and highlights TSPAN18 as a potential therapeutic target.

• Sulfo-Cy5 NHS Ester: Hydrophilic Dye for Advanced Protein La

  2026-07-27

  Sulfo-Cy5 NHS ester is a sulfonated, highly water-soluble fluorescent dye optimized for amine-reactive labeling of biomolecules in aqueous environments. With excitation/emission maxima of 646/662 nm and high extinction coefficient, it enables robust protein conjugation for fluorescence imaging—especially where solvent-free protocols are critical.

• Bufalin as a Precision STK33 Degrader in TNBC Research

  2026-07-27

  Explore how Bufalin, a cardiotonic steroid, acts as a selective degrader of STK33 in triple-negative breast cancer (TNBC) research. This article delivers a mechanistic deep dive and practical guidance, setting itself apart with a focus on molecular targeting for advanced oncology workflows.

• SB 202190: Transforming Translational Research on p38 MAPK

  2026-07-26

  This thought-leadership article unpacks the mechanistic power and translational promise of SB202190 (FHPI) as a highly selective p38 MAP kinase inhibitor. Integrating primary literature on regulated cell death mechanisms with cutting-edge evidence from disease models, it offers strategic guidance for researchers targeting inflammation, cancer, and neurodegeneration. By bridging molecular insight, experimental best practices, and clinical relevance, the article empowers investigators to leverage SB 202190 for next-generation translational workflows—moving decisively beyond conventional product guides.

• Multiomics Insights into Acute Liver Injury and Therapeutic

  2026-07-25

  This study employs an integrated multiomics approach to dissect the molecular mechanisms of acute liver injury and evaluate the therapeutic actions of bifendate and muaddil sapra. By mapping co-expression gene modules and regulatory networks, the research identifies novel drug targets and clarifies how distinct regulatory elements influence acute liver injury progression and treatment.

• Telmisartan as an Angiotensin II Receptor Antagonist in Rese

  2026-07-24

  Telmisartan is redefining hypertension and cardiac hypertrophy models as a potent angiotensin II receptor antagonist. This article details actionable protocols, advanced applications, and troubleshooting strategies to ensure reproducible, high-impact cardiovascular disease research.

• IBDV VP3 Protein Drives IRF7 Degradation to Aid Viral Replic

  2026-07-24

  This study reveals that infectious bursal disease virus (IBDV) uses its VP3 protein to promote degradation of interferon regulatory factor 7 (IRF7), thereby suppressing type I interferon responses and enhancing viral replication in chicken cells. These insights uncover a specific mechanism of immune evasion and highlight new potential targets for antiviral intervention.

• Dual-Action Kinase Inhibitors Modulate p38α MAPK Dephosphory

  2026-07-23

  The reference study uncovers that certain ATP-competitive p38α MAP kinase inhibitors not only block kinase activity but also promote dephosphorylation by stabilizing a phosphatase-accessible conformation. This dual-action mechanism offers a new strategy for designing selective kinase inhibitors, with broad implications for inflammation, type 1 diabetes, and neuroregeneration research.

16654 records 1/1111 page Next 12345 下5页 Last page